3Van Biesen W, Vanholder RC, Veys N, et al. An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol, 2000,11( 1 ) :116 - 125.
4Hoy WE, Kondalsamy-Chennakesavan S, Scheppingen J, et al. A chronic disease outreach program for Aboriginal communities. Kidney Int, 2005, (98) (Suppl) : S76 - 82.
5K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002,39 (2 Suppl 1 ) :S1-266.
7Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int, 2006,69(10) :1726 -1732.
8Combe C, McCullough KP, Asano Y, et al. Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS) : nutrition guidelines, indicators, and practices. Am J Kidney Dis, 2004,44(5 Suppl 2) :39 -46.
9White CT, Gowrishankar M, Feber J, et al. Clinical practice guidelines for pediatric peritoneal dialysis. Pediatr Nephrol, 2006,21 (8) :1059 - 1066.
10Dombros N, Dratwa M, Feriani M, et al. European best practice guidelines for peritoneal dialysis. 2 The initiation of dialysis. Nephrol Dial Transplant, 2005,20( Suppl 9) :ix3 - ix7.
10Kim J, Pisoni RL, Danese M, et al. Achievement of proposed NKF-K/DOQI bone metabolism and disease guidelines: results from the dialysis outcomes and practice patterns study(DOPPS).American Society of Nephrology 2003 Renal Week.November 12-17.
9Ward MM. Changes in the incidence of end stage renal disease due to lupus nephritis in the United States, 1996 - 2004. J Rheumatol,2009, 36(1) :63-67.
10Costenbader KH, Desai A, Alarc6n GS,et ai.Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.Arthritis Rheum,2011,63(6): 1681-1688.
